61958-2301 : Vemlidy 25 mg Oral Tablet


NDC61958-2301
Labeler: Gilead Sciences, Inc.
Product Type: Human Prescription Drug
Drug Name:  Vemlidy
Dosage Form: Oral Tablet
Application #: NDA208464
Rev. Date: 


Appearance:


Markings: GSI;25
Shapes:  Round
Colors:  Yellow
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 61958-2301-1: 30 TABLET IN 1 BOTTLE, PLASTIC (61958‑2301‑1)

Active Ingredients:

  • Tenofovir Alafenamide Fumarate

Dosage Strength:

  • 25 mg

Inactive Ingredients:

  • Lactose Monohydrate
  • Microcrystalline Cellulose
  • Croscarmellose Sodium
  • Magnesium Stearate
  • Polyvinyl Alcohol, Unspecified
  • Titanium Dioxide
  • Polyethylene Glycol 3350
  • Talc
  • Ferric Oxide Yellow

Pharmaceutical Classes:

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleosides [CS]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61958-2301 QR Code

< Prev: 61958-2203Next: 61958-2401 >

Related Discussions:

Tenofovir with primolut N
Actually I am taking tenofovir from the past 2 years. Now I need to take primolut N. Can I take it with tenofovir? One o...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 August 2018.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA